VEGF blockade impairs angiogenesis and vascular remodeling, mechanisms crucial in cirrhotic patients with portal hypertension, thereby predisposing to both thrombotic and hemorrhagic complications, including variceal bleeding and VTE [103,130,131,132]. This evidence concerns the gene VEGFA and liver disorder.